Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

United States Generic Injectables Market: By Therapeutic Area: Oncology, Anaesthesia, Anti-Infectives, Parenteral Nutrition, Cardiovascular; By Containers; By Distributional Channel; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments

United States Generic Injectables Market Outlook

The United States generic injectables market size reached a value of almost USD 12.3 billion in 2020. The industry is further expected to grow at a CAGR of 7% between 2021 and 2026 to reach a value of almost USD 18.5 billion by 2026.

 

United States Generic Injectables Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The United States generic injectables market is driven by the extensive use of the product owing to an increase in the lifestyle ailments caused by non-nutritive diet, sedentary lifestyles, and ageing population. The market significantly contributes to the growth of the overall North America generic injectables market, which is the leading regional market on a global scale.

On account of several benefits offered by generic injectables, the government is supporting its manufacturers in the United States. In addition to this, several factors, such as an increase in the drug shortage in the United States, ageing population, rising prevalence of chronic and lifestyle diseases, and patent expiry of a number of blockbuster drugs, are significantly contributing to the market growth.

 

Properties and Applications

Generic injectables are bioequivalent of branded drugs that are not covered by patents. Their purpose is to rapidly transport the drug into the body, bypassing the first-pass metabolism. On account of their similar quality, strength, effect, dosage, and active ingredient, generic injectables are as effective and safe as innovator injectables. They are used in the treatment of diseases like cancer, diabetes, rheumatoid arthritis, osteoporosis, osteoarthritis, respiratory, and cardiovascular disorders.

 

United States Generic Injectables Market By Containers

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The market is segmented on the basis of the therapeutic area into:

  • Oncology
  • Anaesthesia
  • Anti-Infectives
  • Parenteral Nutrition
  • Cardiovascular

On the basis of containers, the industry is divided into:

  • Vials
  • Ampoules
  • Premix
  • Prefilled Syringes
  • Others

On the basis of the distribution channel, the market is segregated into:

  • Retail Pharmacies 
  • Hospital Pharmacies

 

United States Generic Injectables Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The generic injectables industry in the United States is driven by the increase in the demand for the product owing to increasing investment for the development of generic drugs by the United States government. This will help promote the market and decrease the expenditure on healthcare in the United States. Moreover, shortages of drugs, along with quick approvals by the USFDA, will fuel the manufacturing of these drugs, thereby increasing the market growth. Further, many of the branded injectables firms are expected to lose their patent protection in the coming years, as a result offering enormous lucrative opportunities to the manufacturers of generic injectables.

 

Competitive Landscape

The report gives a detailed analysis of the following key players in the United States generic injectables market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Pfizer Inc.
  • Hikma Pharmaceuticals PLC
  • Sandoz International GmbH
  • Teligent, Inc
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Therapeutic Area, Containers, Distribution Channel
Breakup by Therapeutic Area Oncology, Anaesthesia, Anti-Infectives, Parenteral Nutrition, Cardiovascular
Breakup by Containers Vials, Ampoules, Premix, Prefilled Syringes, Others
Breakup by Distribution Channel Retail Pharmacies, Hospital Pharmacies
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Pfizer Inc., Hikma Pharmaceuticals PLC, Sandoz International GmbH, Teligent, Inc, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    United States
7    Industry Opportunities and Challenges
8    Global Generic Drug Market Overview

    8.1    Key Industry Highlights
    8.2    Global Generic Drug Historical Market (2017-2021) 
    8.3    Global Generic Drug Market Forecast (2022-2027)
    8.4    Global Generic Drug Market by Region
        8.4.1    Market Share
            8.4.1.1    North America
            8.4.1.2    Europe
            8.4.1.3    Asia Pacific
            8.4.1.4    Latin America
            8.4.1.5    Latin America
9    Global Generic Injectables Drug Market Overview
    9.1    Key Industry Highlights
    9.2    Global Generic Injectables Historical Market (2017-2021) 
    9.3    Global Generic Injectables Market Forecast (2022-2027)
    9.4    Global Generic Injectables Market by Therapeutic Area
    9.5    Global Generic Injectables Market by Containers
    9.6    Global Generic Injectables Market by Distribution Channel
    9.7    Global Generic Injectables Market by Region
        9.7.1    Market Share
            9.7.1.1    North America
            9.7.1.2    Europe
            9.7.1.3    Asia Pacific
            9.7.1.4    Latin America
            9.7.1.5    Latin America
10    United States Generic Drug Market Overview
    10.1    Key Industry Highlights
    10.2    United States Generic Drug Historical Market (2017-2021) 
    10.3    United States Generic Drug Market Forecast (2022-2027)
11    United States Generic Injectables Market Analysis
    11.1    Key Industry Highlights
    11.2    United States Generic Injectables Historical Market (2017-2021) 
    11.3    United States Generic Injectables Market Forecast (2022-2027)
    11.4    United States Generic Injectables Market by Therapeutic Area
        11.4.1    Oncology
            11.4.1.1    Market Share
            11.4.1.2    Historical Trend (2017-2021)
            11.4.1.3    Forecast Trend (2022-2027)
        11.4.2    Anaesthesia
            11.4.2.1    Market Share
            11.4.2.2    Historical Trend (2017-2021)
            11.4.2.3    Forecast Trend (2022-2027)
        11.4.3    Anti-Infectives
            11.4.3.1    Market Share
            11.4.3.2    Historical Trend (2017-2021)
            11.4.3.3    Forecast Trend (2022-2027)
        11.4.4    Parenteral Nutrition
            11.4.4.1    Market Share
            11.4.4.2    Historical Trend (2017-2021)
            11.4.4.3    Forecast Trend (2022-2027)
        11.4.5    Cardiovascular
            11.4.5.1    Market Share
            11.4.5.2    Historical Trend (2017-2021)
            11.4.5.3    Forecast Trend (2022-2027)
    11.5    United States Generic Injectables Market by Containers
        11.5.1    Vials
            11.5.1.1    Market Share
            11.5.1.2    Historical Trend (2017-2021)
            11.5.1.3    Forecast Trend (2022-2027)
        11.5.2    Ampoules
            11.5.2.1    Market Share
            11.5.2.2    Historical Trend (2017-2021)
            11.5.2.3    Forecast Trend (2022-2027)
        11.5.3    Premix
            11.5.3.1    Market Share
            11.5.3.2    Historical Trend (2017-2021)
            11.5.3.3    Forecast Trend (2022-2027)
        11.5.4    Prefilled Syringes
            11.5.4.1    Market Share
            11.5.4.2    Historical Trend (2017-2021)
            11.5.4.3    Forecast Trend (2022-2027)
        11.5.5    Others
    11.6    United States Generic Injectables Market by Distribution Channel
        11.6.1    Retail Pharmacies
            11.6.1.1    Market Share
            11.6.1.2    Historical Trend (2017-2021)
            11.6.1.3    Forecast Trend (2022-2027)
        11.6.2    Hospital Pharmacies
            11.6.2.1    Market Share
            11.6.2.2    Historical Trend (2017-2021)
            11.6.2.3    Forecast Trend (2022-2027)
12    Market Dynamics
    12.1    SWOT Analysis
        12.1.1    Strengths
        12.1.2    Weaknesses
        12.1.3    Opportunities
        12.1.4    Threats
    12.2    Porter’s Five Forces Analysis
        12.2.1    Supplier’s Power
        12.2.2    Buyers Power
        12.2.3    Threat of New Entrants
        12.2.4    Degree of Rivalry
        12.2.5    Threat of Substitutes
    12.3    Key Indicators for Demand
    12.4    Key Indicators for Price
13    Value Chain Analysis
14    Competitive Landscape
    14.1    Market Structure
    14.2    Key Players’ Market Share
    14.3    Company Profiles
        14.3.1    Pfizer Inc.
            14.3.1.1    Company Overview
            14.3.1.2    Product Portfolio
            14.3.1.3    Demographic Reach and Achievements
            14.3.1.4    Financial Summary
            14.3.1.5    Certifications
        14.3.2    Hikma Pharmaceuticals PLC
            14.3.2.1    Company Overview
            14.3.2.2    Product Portfolio
            14.3.2.3    Demographic Reach and Achievements
            14.3.2.4    Financial Summary
            14.3.2.5    Certifications
        14.3.3    Sandoz International GmbH
            14.3.3.1    Company Overview
            14.3.3.2    Product Portfolio
            14.3.3.3    Demographic Reach and Achievements
            14.3.3.4    Financial Summary
            14.3.3.5    Certifications
        14.3.4    Teligent, Inc
            14.3.4.1    Company Overview
            14.3.4.2    Product Portfolio
            14.3.4.3    Demographic Reach and Achievements
            14.3.4.4    Financial Summary
            14.3.4.5    Certifications
        14.3.5    Others
15    Industry Events and Developments


List of Key Figures and Tables

1.    Global Generic Drug Market: Key Industry Highlights, 2016 and 2026
2.    Global Generic Injectables Market: Key Industry Highlights, 2016 and 2026
3.    United States Generic Drug Market: Key Industry Highlights, 2016 and 2026
4.    United States Generic Injectables Market: Key Industry Highlights, 2016 and 2026
5.    United States Generic Injectables Historical Market: Breakup by Therapeutic Area (USD Billion), 2017-2021
6.    United States Generic Injectables Market Forecast: Breakup by Therapeutic Area (USD Billion), 2022-2027
7.    United States Generic Injectables Historical Market: Breakup by Containers (USD Billion), 2017-2021
8.    United States Generic Injectables Market Forecast: Breakup by Containers (USD Billion), 2022-2027
9.    United States Generic Injectables Historical Market: Breakup by Distribution Channel (USD Billion), 2017-2021
10.    United States Generic Injectables Market Forecast: Breakup by Distribution Channel (USD Billion), 2022-2027
11.    United States Generic Injection Market Structure

Key Questions Answered in the Report

In 2020, the market in the United States attained a value of nearly USD 12.3 billion.

The market is projected to grow at a CAGR of 7% in the forecast period of 2022-2027.

The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 18.5 billion by 2026.
 

The major drivers of the industry, such as increasing investment into the development of generic drugs by the government and quick approvals by the USFDA, are expected to aid the market growth.
 

The key market trend guiding the growth of the generic injectables market includes the expiration of patent protection in the coming years, resulting in lucrative opportunities for growth in the industry.
 

The major therapeutic area of the product in the industry are oncology, anaesthesia, anti-infectives, parenteral nutrition, and cardiovascular.
 

Vials, ampoules, premix, and prefilled syringes, among others, are the major container-types of generic injectables.  
 

Retail pharmacies and hospital pharmacies are the leading distribution channels of generic injectables.
 

The major players in the industry are Pfizer Inc., Hikma Pharmaceuticals PLC, Sandoz International GmbH, and Teligent, Inc, among others.
 

Analyst Review

The United States generic injectables market attained a value of USD 12.3 billion in 2020 driven by increasing governmental investment into the development of generic drugs. Aided by the expiration of patent protection of various blockbuster drugs in the coming years, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 7%. The industry in the United States is projected to reach USD 18.5 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its therapeutic areas, the industry can be segmented into oncology, anaesthesia, anti-infectives, parenteral nutrition, and cardiovascular. On the basis of containers, the industry is divided into vials, ampoules, premix, prefilled syringes, and others. On the distribution channel, the industry is divided into retail pharmacies and hospital pharmacies. The key players in the above market include Pfizer Inc., Hikma Pharmaceuticals PLC, Sandoz International GmbH, Teligent, Inc, and others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER